zika

The Zika Threat

ASM Acts to Counter Zika Virus Outbreak.
Read

The Zika Diaries

Follow Dr. Vincent Racaniello’s lab as they work on Zika
at his Columbia University lab.
Read

Read a Book Chapter about Zika Virus

Werner Slenczka presents an overview of Zika Virus in the book Emerging Infections 10, just published by ASM Press.
Read
Become a member today!
JOIN ASM
Submit to an ASM Journal
SUBMIT
Register for the Beneficial Microbes Conference
REGISTER

EspinoDepartment of Microbiology and Medical Zoology, University of Puerto Rico, School of Medicine

Dr. Ana M. Espino Hernandez was born at Guanabacoa, one of the most ancient towns of the periphery of Havana City, Cuba. She received her undergraduate training at the University of Havana, and graduated with a Bachelor of Biochemistry with First Class of Honors. Dr. Hernandez completed her doctoral research under the supervision of Dr. Carlos M. Finlay at the Institute of Tropical Medicine “Pedro Kourí” of Havana, one of most prestigious science institutions of Cuba, earning a Ph.D. in Medical Sciences. Her doctoral research involved the development of monoclonal antibodies against major excretory-secretory antigens of F. hepatica, and the development of novel and highly sensitive copro-antigen detection assays for early detection of human fascioliasis that were validated in human populations of high and low endemicity. In 1998, Dr. Hernandez moved to Puerto Rico to begin postdoctoral training under the supervision of Dr. George V. Hillyer in the laboratory of Parasite Immunology of School of Medicine. Her postdoctoral research focused on the identification of novel F. hepatica targets for immunoprophylaxis by searching a parasite DNA library, molecular cloning and construction of DNA vaccines. Subsequently, Ana was recruited by the Department of Microbiology and Medical Zoology of University of Puerto Rico where she holds a tenure track position as Associate Professor. At present, Dr. Hernandez has expanded her research to the understanding the immune evasion mechanisms used by parasite during the active infection, and the development of interference RNA interference (RNAi) technology with the aim to expedite the development of safer and more efficacious F. hepatica vaccines.

 

 

TPL_asm2013_SEARCH

91738